MindMed has appointed Brandi Roberts as its Chief Financial Officer. In the role, Roberts will oversee financial strategy, capital planning, accounting, investor relations, and information technology.
Roberts brings finance leadership experience across strategy, reporting, capital planning, and public company operations. Her background aligns with MindMed’s need for financial discipline as the company advances its clinical and corporate priorities.
Why this matters: MindMed’s appointment of a Chief Financial Officer comes at an important stage for a clinical-stage biopharmaceutical company. Strong finance leadership can support capital strategy, investor communication, and operational oversight as the company continues to advance its pipeline.
